Warburg Research Reiterates €51.00 Price Target for Fresenius SE & Co. KGaA (FRA:FRE)

Fresenius SE & Co. KGaA (FRA:FREGet Rating) has been given a €51.00 ($53.68) price objective by research analysts at Warburg Research in a note issued to investors on Tuesday, Borsen Zeitung reports. Warburg Research’s price objective suggests a potential upside of 49.87% from the company’s current price.

Other equities research analysts have also recently issued research reports about the company. Berenberg Bank set a €60.25 ($63.42) price objective on Fresenius SE & Co. KGaA in a report on Friday, April 29th. Sanford C. Bernstein set a €40.00 ($42.11) price objective on Fresenius SE & Co. KGaA in a report on Thursday, March 3rd. Deutsche Bank Rese… set a €36.00 ($37.89) price objective on Fresenius SE & Co. KGaA in a report on Thursday, May 5th. The Goldman Sachs Group set a €49.00 ($51.58) price objective on Fresenius SE & Co. KGaA in a report on Friday, April 1st. Finally, Deutsche Bank Aktiengesellschaft set a €36.00 ($37.89) price objective on Fresenius SE & Co. KGaA in a report on Tuesday, March 1st. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of €43.40 ($45.69).

Shares of FRE stock traded down €1.02 ($1.07) during mid-day trading on Tuesday, hitting €34.03 ($35.82). 1,509,405 shares of the company’s stock were exchanged. Fresenius SE & Co. KGaA has a fifty-two week low of €60.16 ($63.33) and a fifty-two week high of €80.00 ($84.21). The stock has a 50-day simple moving average of €32.69 and a two-hundred day simple moving average of €35.16.

Fresenius SE & Co. KGaA Company Profile (Get Rating)

Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Featured Articles

Analyst Recommendations for Fresenius SE & Co. KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.